Chronic disease index (range: 0 to 8) | |||
---|---|---|---|
Predictors | Model 1 | Model 2 | Model 3 |
TCD4N/TCD8TDEM | 0.038 (-0.01, 0.09) | 0.043 (-0.01, 0.09) | 0.03 (-0.02, 0.08) |
LYMPO/TCD4N | 0.322 (0.24, 0.4) | 0.28 (0.2, 0.36) | 0.261 (0.18, 0.34) |
TCD4EM/TCD4O | 0.005 (-0.01, 0.02) | -0.005 (-0.02, 0.01) | -0.009 (-0.02, 0) |
LYMPO/TCD4CM | -0.206 (-0.28, -0.13) | -0.218 (-0.29, -0.15) | -0.189 (-0.26, -0.12) |
TCD4N/TCD4O | -0.019 (-0.07, 0.03) | -0.03 (-0.08, 0.02) | -0.024 (-0.07, 0.03) |
LYMPO/BN | 0.021 (-0.02, 0.07) | -0.039 (-0.08, 0) | -0.033 (-0.08, 0.01) |
TCD4TDEM/TCD8O | 0.057 (0.03, 0.08) | 0.05 (0.03, 0.07) | 0.03 (0.01, 0.05) |
TCD4N/TCD8N | 0.114 (0.07, 0.16) | -0.017 (-0.07, 0.03) | 0.021 (-0.03, 0.07) |
LYMPO/TCD8EM | -0.023 (-0.04, -0.01) | -0.018 (-0.03, 0) | -0.018 (-0.03, 0) |
Age | - | 0.04 (0.04, 0.04) | 0.037 (0.03, 0.04) |
Gender: Female | - | 0.147 (0.07, 0.22) | 0.133 (0.06, 0.21) |
Race: Black | - | - | 0.232 (0.12, 0.34) |
Race: Hispanic | - | - | -0.187 (-0.31, -0.06) |
Race: Other | - | - | 0.052 (-0.15, 0.26) |
Education: Lower secondary | - | - | 0.317 (0.15, 0.49) |
Education: Upper secondary | - | - | -0.072 (-0.22, 0.08) |
Education: Above upper secondary | - | - | -0.241 (-0.39, -0.09) |
CMV: Reactive | - | - | 0.046 (-0.06, 0.15) |
Intercept | 2.421 (2.27, 2.57) | -0.183 (-0.5, 0.13) | -0.055 (-0.44, 0.33) |
Self-reported health (range: 1 to 5) | |||
Predictors | Model 1 | Model 2 | Model 3 |
TCD4N/TCD8TDEM | 0.021 (-0.01, 0.06) | 0.02 (-0.02, 0.06) | -0.001 (-0.04, 0.03) |
LYMPO/TCD4N | 0.112 (0.06, 0.17) | 0.115 (0.06, 0.17) | 0.061 (0.01, 0.12) |
TCD4EM/TCD4O | 0.013 (0, 0.02) | 0.012 (0, 0.02) | 0.002 (-0.01, 0.01) |
LYMPO/TCD4CM | -0.074 (-0.12, -0.02) | -0.077 (-0.13, -0.03) | -0.042 (-0.09, 0.01) |
TCD4N/TCD4O | -0.051 (-0.09, -0.02) | -0.052 (-0.09, -0.02) | -0.034 (-0.07, 0) |
LYMPO/BN | 0.02 (-0.01, 0.05) | 0.019 (-0.01, 0.05) | 0.041 (0.01, 0.07) |
TCD4TDEM/TCD8O | 0.04 (0.02, 0.06) | 0.036 (0.02, 0.05) | 0.015 (0, 0.03) |
TCD4N/TCD8N | -0.022 (-0.05, 0.01) | -0.027 (-0.06, 0.01) | 0.002 (-0.03, 0.04) |
LYMPO/TCD8EM | -0.004 (-0.02, 0.01) | -0.004 (-0.02, 0.01) | -0.004 (-0.02, 0.01) |
Age | - | 0.003 (0, 0.01) | 0.004 (0, 0.01) |
Gender: Female | - | 0.075 (0.02, 0.13) | 0.057 (0, 0.11) |
Race: Black | - | - | 0.278 (0.2, 0.35) |
Race: Hispanic | - | - | 0.301 (0.22, 0.38) |
Race: Other | - | - | 0.334 (0.19, 0.48) |
Education: Lower secondary | - | - | -0.063 (-0.18, 0.05) |
Education: Upper secondary | - | - | -0.336 (-0.44, -0.23) |
Education: Above upper secondary | - | - | -0.584 (-0.69, -0.48) |
CMV: Reactive | - | - | -0.004 (-0.08, 0.07) |
Intercept | 3.103 (3, 3.21) | 2.929 (2.66, 3.13) | 2.936 (2.67, 3.2) |
Frailty level (range: 1 to 4) | |||
Predictors | Model 1 | Model 2 | Model 3 |
TCD4N/TCD8TDEM | 0.041 (0, 0.08) | 0.041 (0, 0.08) | 0.02 (-0.02, 0.06) |
LYMPO/TCD4N | 0.185 (0.13, 0.24) | 0.172 (0.11, 0.23) | 0.129 (0.07, 0.19) |
TCD4EM/TCD4O | 0.016 (0.01, 0.02) | 0.009 (0, 0.02) | -0.001 (-0.01, 0.01) |
LYMPO/TCD4CM | -0.132 (-0.19, -0.08) | -0.145 (-0.2, -0.09) | -0.106 (-0.16, -0.06) |
TCD4N/TCD4O | -0.056 (-0.09, -0.02) | -0.064 (-0.1, -0.03) | -0.046 (-0.08, -0.01) |
LYMPO/BN | 0.021 (-0.01, 0.05) | -0.01 (-0.04, 0.02) | 0.007 (-0.02, 0.04) |
TCD4TDEM/TCD8O | 0.068 (0.05, 0.08) | 0.055 (0.04, 0.07) | 0.028 (0.01, 0.05) |
TCD4N/TCD8N | 0.048 (0.02, 0.08) | -0.029 (-0.06, 0.01) | 0.012 (-0.02, 0.05) |
LYMPO/TCD8EM | -0.01 (-0.02, 0) | -0.007 (-0.02, 0) | -0.007 (-0.02, 0) |
Age | - | 0.026 (0.02, 0.03) | 0.025 (0.02, 0.03) |
Gender: Female | - | 0.258 (0.2, 0.31) | 0.236 (0.18, 0.29) |
Race: Black | - | - | 0.298 (0.22, 0.37) |
Race: Hispanic | - | - | 0.068 (-0.02, 0.15) |
Race: Other | - | - | 0.121 (-0.02, 0.27) |
Education: Lower secondary | - | - | 0.076 (-0.04, 0.2) |
Education: Upper secondary | - | - | -0.259 (-0.37, -0.15) |
Education: Above upper secondary | - | - | -0.554 (-0.66, -0.45) |
CMV: Reactive | - | - | 0.051 (-0.02, 0.12) |
Intercept | 2.494 (2.38, 2.6) | 0.645 (0.42, 0.87) | 0.801 (0.53, 1.07) |